Delivery Order SPE2DB24D3015-SPE2DB25FFZDA

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,275.59, is a Delivery Order for the supply of Armour Thyroid 30 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of December 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.75 firm fixed-price delivery order is for the supply of Armour Thyroid 90 mg tablets. The contract has an ultimate completion date of January 9, 2024 and was awarded on January 8, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a ceiling value of $5,884.09. The contract is for the supply of Armour Thyroid 30 mg tablets in 100-count bottles. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 19, 2024. The contract is a firm fixed-price delivery order and does not have any set-aside designation, indicating open competition....
This federal contract award, SPE2DB20D7059|SPE2DB25FQEV0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,718.10 delivery order contract is for the supply of 4,568,028,738 tablets of Armour Thyroid 60 mg, a prescription medication. The contract is a firm fixed-price, non-set-aside award with a completion date of April 28, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,384.88 firm fixed-price delivery order is for the supply of Armour Thyroid 90 mg tablets, a medication used to treat hypothyroidism. The contract has an ultimate completion date of November 1, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,022.12, is for the supply of Armour Thyroid 90 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,522.70, is for the delivery of Armour Thyroid 15 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,295.49, is for the delivery of Armour Thyroid 90 mg tablets. It is a firm fixed-price delivery order contract with a period of performance ending on May 9, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $9,148.20 firm fixed price delivery order is for the supply of Armour Thyroid 60 mg tablets. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Armour Thyroid 90 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,859.71 and a completion date of June 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZDA
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,987.24, is a delivery order for the supply of Armour Thyroid 90 mg tablets. The contract has an ultimate completion date of April 29, 2025 and is a firm fixed-price contract.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government agencies.

The contract award is not designated as a set-aside, indicating open competition. No subcontractors are mentioned in the information provided.

Generated 7/28/25, 11:07 AM